Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
---|---|---|---|---|---|---|---|---|---|
6,72% | 2,6 M | 66,74% | 3,18% | 2050-07-09 | 2 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
6,62% | 6,51 M | 65,66% | 3,38% | 2060-07-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
6,20% | 2,52 M | 75,00% | 3,03% | 2040-07-09 | 1,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,86% | 1,6 M | 99,30% | 5,80% | 2064-07-05 | 500 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,72% | 7,38 M | 99,20% | 5,65% | 2054-07-05 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5,62% | 61 K | 96,50% | 5,25% | 2045-06-23 | 500,41 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
5,46% | 6,8 M | 101,83% | 5,65% | 2044-07-05 | 800 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,13% | 16,8 M | 101,09% | 5,30% | 2034-07-05 | 1,1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,05% | 2,65 M | 87,88% | 2,05% | 2030-03-31 | 2,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4,87% | 763 K | 99,74% | 4,00% | 2025-06-23 | 800,17 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
4,68% | 0 | 76,06% | 2,00% | 2040-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
4,61% | 800 K | 101,23% | 5,00% | 2028-11-26 | 1,73 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4,51% | 0 | 98,10% | 3,20% | 2026-09-23 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Shire Acquisitions Investments Ireland DAC |
3,71% | 0 | 86,53% | 1,38% | 2032-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,34% | 0 | 98,36% | 3,00% | 2030-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,25% | 0 | 91,44% | 1,00% | 2029-07-09 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,00% | 0 | 95,07% | 0,75% | 2027-07-09 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,88% | 0 | 98,97% | 2,25% | 2026-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,71% | 0 | 116,57% | 5,00% | 2028-11-26 | 22,68 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
— | — | — | 5,00% | 2028-11-26 | 22,68 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4,00% | 2025-06-23 | 303 K USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |